Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HL vs GSK✓SelectedUSD · GSKHL vs GSK performance historyLatest closeAs of-6.72%11/16
Stock and ETF performance explorer

HL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+101.1%
GSK return
+46.9%
Excess return
+54.2%
Maximum drawdown
-61.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-6.7%-0.1%-6.6%-6.7%
7D-20.7%-1.3%-19.4%-20.3%
30D-20.1%+2.7%-22.9%-20.9%
3M-33.5%+2.7%-36.2%-34.1%
6M-30.7%+3.3%-34.0%-31.9%
YTD-36.3%+6.5%-42.7%-38.5%
1Y-16.2%+10.7%-26.9%-20.4%
3Y+176.5%+64.4%+112.2%+106.8%
5Y+101.1%+46.7%+54.4%+42.6%
All+101.1%+46.9%+54.2%+42.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling